EA202191318A1 - TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION - Google Patents

TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION

Info

Publication number
EA202191318A1
EA202191318A1 EA202191318A EA202191318A EA202191318A1 EA 202191318 A1 EA202191318 A1 EA 202191318A1 EA 202191318 A EA202191318 A EA 202191318A EA 202191318 A EA202191318 A EA 202191318A EA 202191318 A1 EA202191318 A1 EA 202191318A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
compositions
application
tyrosine kinase
kinase inhibitors
Prior art date
Application number
EA202191318A
Other languages
Russian (ru)
Inventor
Бань Фу
Иньлун Ли
Вэй Жэнь
Цзе Чэнь
Сянюн ЛЮ
Цзябин ВАН
Лемин ДИН
Original Assignee
Бетта Фармасьютикалз Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бетта Фармасьютикалз Ко., Лтд filed Critical Бетта Фармасьютикалз Ко., Лтд
Priority claimed from PCT/CN2019/123719 external-priority patent/WO2020114499A1/en
Publication of EA202191318A1 publication Critical patent/EA202191318A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к соединениям формулы I, способам использования соединений в качестве ингибиторов Trk и фармацевтическим составам, содержащим такие соединения. Соединения полезны для лечения, предотвращения или облегчения заболеваний или расстройств, таких как рак или инфекции.The present invention relates to compounds of formula I, methods of using the compounds as Trk inhibitors, and pharmaceutical compositions containing such compounds. The compounds are useful in the treatment, prevention, or amelioration of diseases or disorders such as cancer or infections.

EA202191318A 2019-05-09 2019-12-06 TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION EA202191318A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2019086204 2019-05-09
PCT/CN2019/123719 WO2020114499A1 (en) 2018-12-07 2019-12-06 Tyrosine kinase inhibitors, compositions and methods there of

Publications (1)

Publication Number Publication Date
EA202191318A1 true EA202191318A1 (en) 2021-10-19

Family

ID=78572628

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191318A EA202191318A1 (en) 2019-05-09 2019-12-06 TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202191318A1 (en)

Similar Documents

Publication Publication Date Title
EA202092896A1 (en) HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
EA202091267A1 (en) 1,2,4-OXADIAZOLIC COMPOUNDS AS INHIBITORS OF CD47 SIGNAL PATHWAYS
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
EA202092003A1 (en) COMPOUNDS FOR TREATMENT OF GENTINGTON'S DISEASE
EA202092899A1 (en) HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
EA201992878A1 (en) COMPOUNDS FOR TREATMENT OF HUNTINGTON'S DISEASE
EA202091709A1 (en) DNA PC INHIBITORS
EA201891494A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
MX2021006619A (en) Tyrosine kinase inhibitors, compositions and methods there of.
EA201792047A1 (en) NEW CONNECTIONS
MX2021014455A (en) Dna-dependent protein kinase inhibitor.
EA202091708A1 (en) DNA PC INHIBITORS
EA201991894A1 (en) PIPERIDINE-SUBSTITUTED Mnk INHIBITORS AND RELATED WAYS
EA201992137A1 (en) Pyrimidopyrimidinones as Wee-1 Kinase Inhibitors
EA201990678A1 (en) Heteroarylcarboxamide Compounds as Ripk2 Inhibitors
EA201692260A1 (en) 1,3,4-TIADIAZOLE COMPOUNDS AND THEIR APPLICATION IN CANCER TREATMENT
EA202192905A1 (en) COMPOUNDS CONTAINING N-METHYL-2-PYRIDONE AND PHARMACEUTICALLY ACCEPTABLE SALTS
EA202191478A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202190464A1 (en) SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS
EA202092326A1 (en) BUMETHANIDE DERIVATIVES FOR THE TREATMENT OF HYPERHYDROSIS
EA202092446A1 (en) THIAZOL- OR THIADIAZOL-SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS Vps34 INHIBITORS
EA202191477A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202191318A1 (en) TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS OF THEIR APPLICATION
MX2023000198A (en) Atr inhibitors and uses thereof.